StockData
Contineum Therapeutics, Inc. logo

Contineum Therapeutics, Inc. (CTNM) stock

CTNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/30
$9.55−0.12 (-1.24%)

Close on Nov 17, 2026Market cap $359.28MP/E –Yield –

Contineum Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Contineum Therapeutics's price to book ratio was 1.5× on Nov 11, 2026, against 1.6× a year earlier. Over the last 2 years it ranged from 0.4× to 2.3×, with a median of 1.4×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.5×−0.2
2025Dec 31, 20251.7×+0.7
2024Dec 31, 20241.0×–

More Contineum Therapeutics figures

See a number that looks wrong?